Genetic and Environmental Determinants of Multiple Sclerosis: Insights from a UK Biobank Longitudinal Study
Multiple sclerosis (MS) is a complex immune-mediated disease of the central nervous system characterized by demyelination, gliosis, and progressive neuronal loss. It remains one of the leading causes of non-traumatic neurological disability among young adults. Despite extensive research, its etiology is not fully understood, largely due to its multifactorial nature involving genetic predisposition, environmental exposures, and early life influences. The study by Nova et al. (2024) provides a significant advancement by examining how these factors influence not only the risk of MS but also the timing of diagnosis using longitudinal data from the UK Biobank .
A Shift in Methodology: From Retrospective to Time-to-Event Analysis
Traditional MS research has relied heavily on retrospective case–control designs, which estimate lifetime risk using odds ratios but fail to capture temporal dynamics. In contrast, this study employs a Cox proportional hazards model within a time-to-event framework, allowing for the estimation of instantaneous risk (hazard ratios) across different ages. This methodological shift is crucial because it accounts for censoring, varying follow-up durations, and age-dependent effects—factors that are often overlooked in conventional analyses . By tracking individuals from birth to diagnosis or censoring, the study offers a more nuanced understanding of disease onset.
Genetic Risk and Its Age-Dependent Influence
A central component of the study is the use of a multiple sclerosis polygenic risk score (MS-PRS), which aggregates the effects of numerous genetic variants across the genome. The findings reveal a pronounced age-dependent effect: individuals with higher MS-PRS exhibit significantly elevated risk at younger ages, with hazard ratios decreasing progressively over time. For instance, a 2 standard deviation increase in MS-PRS corresponds to a hazard ratio of 6.40 at age 20, declining to 2.23 by age 60 . This indicates that genetic susceptibility not only increases overall risk but also accelerates disease onset, a pattern that would be underestimated in static models.
Sex Differences and Biological Implications
The study also highlights a strong sex-based disparity in MS risk. Females demonstrate a substantially higher hazard compared to males, particularly at younger ages. As illustrated in the figure on page 5, the hazard ratio for females versus males decreases from approximately 3.88 at age 20 to 2.15 at age 60 . This trend suggests that biological factors such as sex hormones, immune regulation, and X-linked genetic variants may play a more critical role during early adulthood. Importantly, the interaction between female sex and high genetic risk appears synergistic, amplifying susceptibility beyond additive expectations.
Environmental and Early Life Determinants
Beyond genetics, several environmental and early life factors were found to significantly influence MS risk. Smoking and prior infectious mononucleosis (IM), a clinical manifestation of Epstein–Barr virus infection, were associated with increased hazards (HR = 1.69 and HR = 2.03, respectively) . Additionally, individuals born outside the fall season exhibited higher risk, potentially reflecting prenatal vitamin D deficiency due to reduced sunlight exposure. Interestingly, factors such as breastfeeding, maternal smoking at birth, and sibling number did not show statistically significant effects, although subtle trends were observed. These findings reinforce the complex interplay between environmental exposures and immune system development.
Interaction Effects and Risk Stratification
A notable contribution of this study lies in its analysis of interaction effects on both additive and multiplicative scales. Positive additive interactions were observed between high MS-PRS and factors such as female sex, smoking, and IM diagnosis, indicating that combined exposures substantially elevate risk. For example, as described in the cumulative incidence curves on page 6, individuals with high genetic risk, smoking history, and IM diagnosis can reach up to a 10% lifetime probability of MS diagnosis in females . These interaction effects underscore the importance of integrative risk modeling for personalized prediction and prevention strategies.
Implications, Limitations, and Future Directions
While the study offers valuable insights, several limitations must be acknowledged. The use of diagnosis age as a proxy for disease onset may introduce bias, and the cohort’s restriction to White individuals born in England limits generalizability. Additionally, reliance on clinical records and self-reported data may affect diagnostic accuracy. Nevertheless, the study demonstrates the power of longitudinal, time-to-event approaches in uncovering age-dependent risk dynamics. Future research should aim to replicate these findings in more diverse populations and incorporate additional biomarkers—such as vitamin D levels and EBV antibody titers—to enhance predictive models .
Disclaimer: This blog post is based on the provided research article and is intended for informational purposes only. It is not intended to provide medical advice. Please consult with a healthcare professional for any health concerns.
References:
Zhao-Fleming, H. H., Decker, P. A., Kosel, M. L., Drucker, K. L., Kollmeyer, T., Lachance, D. H., ... & Eckel-Passow, J. (2025). Genomewide association study of a homogeneous multiple sclerosis cohort: Tumefactive demyelination. Multiple Sclerosis Journal, 31(10), 1167-1174.
